Clinical Laserthermia Systems AB (publ) (CLS-B.ST)
- Previous Close
2.7050 - Open
2.7600 - Bid 2.6900 x --
- Ask 2.7000 x --
- Day's Range
2.6200 - 2.7900 - 52 Week Range
2.4300 - 23.4950 - Volume
73,659 - Avg. Volume
108,649 - Market Cap (intraday)
67.246M - Beta (5Y Monthly) 0.03
- PE Ratio (TTM)
-- - EPS (TTM)
-3.0900 - Earnings Date Aug 15, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
12.00
Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. The company offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. It also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers provides multiple options to control treatment. In addition, the company offers various gauge laser applicators, as well as provides temperature and treatment monitoring devices. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.
www.clinicallaser.seRecent News: CLS-B.ST
View MorePerformance Overview: CLS-B.ST
Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CLS-B.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CLS-B.ST
View MoreValuation Measures
Market Cap
67.25M
Enterprise Value
39.59M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.34
Price/Book (mrq)
0.91
Enterprise Value/Revenue
1.97
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-250.51%
Return on Assets (ttm)
-40.94%
Return on Equity (ttm)
-85.15%
Revenue (ttm)
20.14M
Net Income Avi to Common (ttm)
-50.45M
Diluted EPS (ttm)
-3.0900
Balance Sheet and Cash Flow
Total Cash (mrq)
27.87M
Total Debt/Equity (mrq)
0.32%
Levered Free Cash Flow (ttm)
-36.76M